CENTESSA PHARMACEUTICALS-ADR
CNTANASDAQ🏆 #1151 by market capUS Equity
$40.50▲ $0.00 (+0.00%)
🌙 After hours$40.68▲ 0.45%Regular close · extended-hours price shownTrack CNTA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d▼ 0.1%
14d▼ 0.1%
30d▼ 0.1%
ytd▲ 61.9%
1y▲ 65.8%
🏦Market Cap
$6.27B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
60
Fair
CENTESSA PHARMACEUTICALS-ADR
CNTAAnalyst Ratings
Price
$40.50
Total
14
Raised
1
Lowered
5
Avg PT
$42.00
H / L
$42 / $42
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wells Fargo | Downgraded | Overweight → Equal Weight | 2026-04-20 | $42.00 | +3.70% |
Guggenheim | Downgraded | Buy → Neutral | 2026-04-02 | $28.00 | −30.90% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2026-04-01 | — | — |
Needham | Downgraded | Buy → Hold | 2026-03-31 | $38.00 | −6.20% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-03-31 | $40.00 | −1.20% |
Truist Securities | Reiterated | Buy | 2026-01-29 | — | — |
Chardan Capital | Reiterated | Buy | 2026-01-02 | $30.00 | −25.90% |
Oppenheimer | Reiterated | Outperform | 2025-12-10 | $6.00 | −85.20% |
B. Riley Securities | Reiterated | Buy | 2025-12-01 | — | — |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2024-09-19 | $27.00 | −33.30% |
BMO Capital | Reiterated | Outperform | 2024-09-16 | $20.00 | −50.60% |
Jefferies | Reiterated | Buy | 2024-09-11 | $19.00 | −53.10% |
Goldman Sachs | Reiterated | Neutral | 2023-08-15 | — | — |
SVB Securities | Reiterated | Outperform | 2023-08-15 | — | — |
Institution
Wells Fargo
Downgraded · Overweight → Equal Weight · 2026-04-20
$42.00
+3.70%
Guggenheim
Downgraded · Buy → Neutral · 2026-04-02
$28.00
−30.90%
Leerink Partners
Downgraded · Outperform → Market Perform · 2026-04-01
—
—
Needham
Downgraded · Buy → Hold · 2026-03-31
$38.00
−6.20%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2026-03-31
$40.00
−1.20%
Truist Securities
Reiterated · Buy · 2026-01-29
—
—
Chardan Capital
Reiterated · Buy · 2026-01-02
$30.00
−25.90%
Oppenheimer
Reiterated · Outperform · 2025-12-10
$6.00
−85.20%
B. Riley Securities
Reiterated · Buy · 2025-12-01
—
—
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2024-09-19
$27.00
−33.30%
BMO Capital
Reiterated · Outperform · 2024-09-16
$20.00
−50.60%
Jefferies
Reiterated · Buy · 2024-09-11
$19.00
−53.10%
Goldman Sachs
Reiterated · Neutral · 2023-08-15
—
—
SVB Securities
Reiterated · Outperform · 2023-08-15
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space